Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma

Biomedicine and Pharmacotherapy

Volumn 67, Issue 8, 2013, Pages 751-755

  Liu, Hong Chun ^a   Zhang, Yi ^a   Wang, Xli Lin ^b   Qin, Wang Sen ^c   Liu, Yu Han ^d   Zhang, Lan ^a   Zhu, Chang Lian ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Fifth People's Hospital   (China)

Author keywords

Esophageal squamous cell carcinoma; Immunohistochemical; RT PCR; TPX2

Indexed keywords

MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN TPX2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR INVASION; UPREGULATION;

ESOPHAGEAL SQUAMOUS CELL CARCINOMA; IMMUNOHISTOCHEMICAL; RT-PCR; TPX2;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; PROGNOSIS; RNA, MESSENGER; UP-REGULATION;

EID: 84887611002     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.04.004     Document Type: Article

References (25)

1. Sakai T., Furihata T., Kawamata H., et al. Molecular and genetic characterization of a non-metastatic human esophageal cancer cell line, the expressing on functional mutated p53. Int J Oncol 2002, 21(3):547-552.
2. Lin Y.C., Wu M.Y., Li D.R., et al. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 2004, 10(22):3235-3239.
3. Lebrbach D.M., Nita M.E., Cecconelo I. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq Gastroenterol 2003, 40(4):256-261.
4. Li H., Yao S.C. Surgical in Chinese publications treatment for carcinoma of the esophageals in Chinese language publications. Br J Surg 1997, 84(6):855-857.
5. Trieseimann N., Armstrong S., Rauw J., et al. Ran modulates spindle assembly by regulating a subset of TPX2 and Kid activities including Aurora-A activation. J Cell Sci 2003, 116(pt23):4791-4798.
6. Vos J.W., Pieuchot L., Evrard J.L., et al. The plant TPX2 protein regulates prospindle assembly before nuclear envelope. Plant Cell 2008, 20(10):2783-2797.
7. Iyer J., Tsai M.Y. A novel role for TPX2 as a scaffold and co-activator protein of the chromosomal passenger complex. Cell Signal 2012, 24(8):1677-1689.
8. Tonon G., Wong K.K., Maulik G., et al. High-resolution genomic pro-files of human lung cancer. Proc Natl Acad Sci USA 2005, 102(27):9625-9630.
9. Kufer T.A., Sillje H.H., Korner R., et al. Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002, 158(4):617-623.
10. Gruss O.J., Wittmann M., Yokoyama H., et al. Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in Hela cells. Nat Cell Biol 2002, 4(11):871-879.
11. Okamura H., Katabuchi H. Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis. Int Rev Cytol 2005, 242:1-54.
12. Wang X.X., Liu R., Jin S.Q., et al. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res 2006, 16(4):356-366.
13. Giet R., Prigent C. Aurora/Ipllp-related kinases, a new oncogenic family of mitotic serine-theronine kinases. J Cell Sci 1999, 112(21):3591-3601.
14. Bischoff J.R., Plowman G.D. The Aurora/Ipllp kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol 1999, 9(11):454-459.
15. Bibby R.A., Tang C., Faisal A., et al. A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2. J Biol Chem 2009, 284(48):33177-33184.
16. Warner S.L., Stephens B.J., Nwokenkwo S., et al. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin Cancer Res 2009, 15(21):6519-6528.
17. Shigeishi H., Fujimoto S., Hiraoka M., et al. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Int J Oncol 2009, 34(6):1565-1571.
18. Scharer C.D., Laycock N., Osunkoya A.O., et al. Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. J Transl Med 2008, 11(6):79.
19. Shigeishi H., Ohta K., Hiraoka M., et al. Expression of TPX2 in salivary gland carcinomas. Oncol Rep 2009, 21(2):341-344.
20. Lin D.M., Ma Y., Xiao T., et al. TPX2 expression and its significance in squamous cell carcinoma of lung. Zhonghua Bing Li Xue Za Zhi 2006, 35(9):540-544.
21. Heidebrecht H.J., Buck F., Steinmann J., et al. P100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood 1997, 90:226-233.
22. Groen A.C., Maresca T.J., Gatlin J.C., et al. Functional overlap of microtubule assembly factors in chromatin-promoted spindle assembly. Mol Biol Cell 2009, 20(11):2766-2773.
23. Rudolph P., Alm P., Olsson H., et al. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer. Hum Pathol 2001, 32(3):311-319.
24. Krams M., Heidebrecht H.J., Hero B., et al. Repp86 expression and outcome in patients with neuroblastoma. J Clin Oncol 2003, 21(9):1810-1818.
25. Ma Y., Lin D., Sun W., et al. Expression of targeting protein for Xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. J Clin Cancer Res 2006, 12(4):1121-1127.